VP of M&A and Corporate Development at a publicly traded post-acute healthcare services organization with over $6B in annual revenue spanning four distinct service lines.
Managed M&A for a primary outpatient service line/division while also supporting other service lines as needed.
Completed 20 multi-location deals in 2024, with an average transaction value of $20M.
Managed a team of two, having established the M&A function to support the outpatient division with joint ventures, partnerships, and acquisitions.
Led outpatient M&A initiatives and projects ranging from small to large-scale transactions, including collaborations with orthopedic surgeons.
Utilizes four sourcing strategies: 1) brokers, 2) investment banks, 3) grassroots referrals from the network, and 4) cold outreach, leveraging analytics to identify opportunities.
Developed and prioritized the pipeline by targeting deals that achieve post-close synergized EBITDA and meet hurdle IRR thresholds.